Abstract
Calcium channel blockers are one of the most useful antihypertensive agents because of their definite blood pressure lowering action. Although the antihypertensive effect of calcium channel blockers is attributed predominantly to the blockade of L-type calcium channels, recent studies demonstrate that the blockade of other subtypes of calcium channels, including T-type and N-type calcium channels, offers renal protective action because of their beneficial action on glomerular capillary pressure, renal fibrotic process, sympathetic nerve activity and aldosterone synthesis. It requires more extensive studies to clarify whether the ostensibly beneficial actions of these calcium channel blockers are available in a clinical setting.
Keywords: Glomerular pressure, renal fibrosis, T-type calcium channel.
Related Books
Cardiac Resynchronization Therapy: An Established Pacing Therapy for Heart Failure and Mechanical Dyssynchrony
Cardiac Care and COVID-19: Perspectives in Medical Practice
4D Fetal Echocardiography
Frontiers in Myocardia
Frontiers in Myocardia
Frontiers in Myocardia
Latest Advances in Clinical and Pre-Clinical Cardiovascular MRI
Electrocardiography (ECG)
Degenerative Aortic Valve Disease, its Mechanism on Progression, its Effect on the Left Ventricle and the Postoperative Results
Focus Concise Animated Dictionary of Cardiology
46